The inhibition of the PI3K/AKT signaling pathway could interrupt insulin-mediated glucose uptake and may also lead to systemic hyperglycemia due to the resulting dysregulation in glucose metabolism in multiple tissues including the liver, muscle, and fat [145]. This evidence concerns the gene AKT1 and Hyperglycemia.